The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Uses and Use Restrictions
Funds may be used for costs associated with establishing and maintaining a prevention and control program directed towards prevention of viral hepatitis infections and its manifestations.
Recipients may only expend funds for reasonable policies, systems and program purposes including personnel, travel, supplies and services, such as reducing transmission of HBV and HCV, preventing and delaying the progress of chronic infection, as well as education and training of the general public and health care providers.
Recipients may not use funds for clinical care.
Recipients may not generally use funding for the purchase of furniture or equipment.
Any such proposed spending must be identified in the budget.
The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is eligible.
Applicants include State or local governments or their Bona Fide Agents, public and private nonprofit organizations, for profit organizations, small, minority, women-owned businesses, universities, colleges, research institutions, hospitals, community-based organizations, faith based organizations, Federally recognized Indian tribal governments, Indian tribes, and Indian tribal organizations.
Additional guidance may be provided in the individual program announcement.
The individual will benefit from the objectives of this program.
No Credentials or documentation are required. This program is excluded from coverage under OMB Circular No. A-87.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. Applicants must download application forms from www.Grants.gov. Applications must be submitted electronically at www.Grants.gov. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms on-line, contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIMS) staff. For this, or further assistance, contact PGO-TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov.
Successful applicants will receive a Notice of Award (NOA) from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be signed by an authorized Grants Management Officer and emailed to the program director and a hard copy mailed to the recipient fiscal officer identified in the application.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Sections 301(a) and 317N of the Public Health Service Act (42 U.S.C. Section 241(a) and 247b-15) as amended.
Range of Approval/Disapproval Time
From 120 to 180 days. Contact the headquarters for application deadline. This will be between 30-60 days from date of publication.
Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under the Patient Protection and Affordable Care Act.
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements. This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Project period is for 1 year with a 12-month budget period. See the following for information on how assistance is awarded/released: Assistance is awarded through Notice of Grant Awards to funded applicants.
Post Assistance Requirements
Program reports are not applicable.
Cash reports are not applicable.
Interim and annual reports will be required as outlined in the Funding Opportunity Announcement (FOA).
The reporting schedule will be based on the requirements listed in the FOA.
Where applicable, the interim progress report is due no less than 90 days before the end of the specified budget period.
Where applicable, the Interim Progress Report will serve as the non-competing continuation application.
Federal Financial Reports (FFRs) (SF425) are required no more than 90 days after the end of the budget period.
Final FFR and progress reports are due no later than 90 days after the end of the project period.
Performance monitoring is not applicable.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. Records must be available for review or audit by appropriate officials of the Federal agency, pass-through entity, and General Accounting Office (GAO). The grantee is to also ensure that the sub-recipients receiving CDC funds also meet these requirements (if total Federal grant or grants funds received exceed $500,000). The grantee should include this requirement in all sub-recipient contracts.
Financial records, supporting documents, statistical records, and all other reports pertinent to the program shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42.
09-2950-2-0-121 - Direct Category A funding: Viral Hepatitis.
(Salaries) FY 12 $250,000; FY 13 est $0; and FY 14 est $0
Range and Average of Financial Assistance
Awards will range from approximately $125,000 to $250,000.
Regulations, Guidelines, and Literature
Regulations governing this program are published under 42 CFR 55b. Guidelines are available. 45 CFR 92, and also HHS Grants Policy Statement at http://www.ahrq.gov/fund/hhspolicy.htm.
Regional or Local Office
None. Viral Hepatitis Program Contact: Jeffrey L. Efird, MPA, Deputy Director, Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, Mailstop G-37, Atlanta, Georgia, 30333. Email: email@example.com
Grants Management Contact: Carla Harper, Grants Management Officer, Department of Health and Human Services, CDC Procurement and Grants Office, 2920 Brandywine Road, MS E-15, Atlanta, GA 30341, Telephone 770-488-2439, Email: CHarper@cdc.gov.
Elizabeth Wolfe Centers for Disease Control and Prevention
1600 Clifton Road, MS E-07
, Atlanta, Georgia 30333 Email: firstname.lastname@example.org Phone: 404-639-8531
Criteria for Selecting Proposals
Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by Division of Viral Hepatitis (DVH), NCHHSTP. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicant will be notified that the application did not meet submission requirements.
CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application and Submission information, subsection "Evaluation Criteria" within the individual funding opportunity announcement.
EU-Startups features 10 success stories about social enterprises across Europe making positive, social impact while making money at the same time.